Zobrazeno 1 - 10
of 61
pro vyhledávání: '"Todd S. Crocenzi"'
Autor:
Robert C. G. Martin, Kerri A. Simo, Paul Hansen, Flavio Rocha, Prejesh Philips, Kelly M. McMasters, Clifton M. Tatum, Lawrence R. Kelly, Michael Driscoll, Vivek R. Sharma, Todd S. Crocenzi, Charles R. Scoggins
Publikováno v:
Annals of Surgical Oncology. 29:5462-5473
Autor:
Margaret A. Tempero, Elizabeth M. Jaffee, Michael Considine, Elana J. Fertig, Beth Onners, Takahiro Tsujikawa, Robert H. Vonderheide, Julie M. Nauroth, Andrew H. Ko, Lisa M. Coussens, Dung T. Le, Dirk G. Brockstedt, Jennifer N. Durham, Daniel A. Laheru, George A. Fisher, Todd S. Crocenzi, Robert A. Anders, Elizabeth A. Sugar, Kim A. Reiss, Ludmila Danilova, Annie A. Wu
Publikováno v:
Clin Cancer Res
Purpose: Two studies in previously treated metastatic pancreatic cancer have been completed combining GVAX pancreas vaccine (GM-CSF–secreting allogeneic pancreatic tumor cells) with cyclophosphamide (Cy) and CRS-207 (live, attenuated Listeria monoc
Autor:
Robert C G, Martin, Kerri A, Simo, Paul, Hansen, Flavio, Rocha, Prejesh, Philips, Kelly M, McMasters, Clifton M, Tatum, Lawrence R, Kelly, Michael, Driscoll, Vivek R, Sharma, Todd S, Crocenzi, Charles R, Scoggins
Publikováno v:
Annals of Surgical Oncology. 29:5474-5475
Autor:
Chloe E. Atreya, Tae Won Kim, Elena Elez, Ravit Geva, Hiroki Hara, Tong Dai, Hiroya Taniguchi, Luis A. Diaz, Dung T. Le, Patrick McKay Boland, Rosine Guimbaud, Salah-Eddin Al-Batran, Todd S. Crocenzi, Matthew Burge, Thierry André, Petr Kavan, Dirk Jäger, Eric Van Cutsem, Yi Cui, Takayuki Yoshino, Patricia Marinello, Bert H. O'Neil
Publikováno v:
Journal of Clinical Oncology
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol 38, iss 1
Scientia
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol 38, iss 1
Scientia
PURPOSE KEYNOTE-164 (NCT02460198) evaluated the antitumor activity of pembrolizumab in previously treated, metastatic, microsatellite instability–high/mismatch repair–deficient (MSI-H/dMMR) colorectal cancer (CRC). METHODS This phase II open-labe
Autor:
Kristina H. Young, Tomoko Yamazaki, Mark H. Whiteford, Nathaniel E Fox, Kayla McCarty, Alejandro F Alice, Todd S. Crocenzi, Amanda V. Hayman, Maria X Kiely, Tiffany C. Blair, Marka R. Crittenden, Michaela Phillips, Andrew J. Gunderson, Rehan Ahmad, David P. O'Brien, Michael J. Gough
Publikováno v:
Nature Communications, Vol 11, Iss 1, Pp 1-13 (2020)
Nature Communications
Nature Communications
Transforming growth factor beta (TGFβ) is a multipotent immunosuppressive cytokine. TGFβ excludes immune cells from tumors, and TGFβ inhibition improves the efficacy of cytotoxic and immune therapies. Using preclinical colorectal cancer models in
Autor:
Frank C. Detterbeck, Hiran C. Fernando, John R. Handy, Scott Firestone, Panos Fidias, Candice Johnstone, Ross M. Bremner, Helen J. Ross, John D. Mitchell, Kenneth A. Kesler, Thomas K. Varghese, Harvey I. Pass, Michael Lanuti, Virginia R. Litle, Todd S. Crocenzi
Publikováno v:
The Annals of thoracic surgery. 107(2)
Autor:
Chan C. Whiting, Andrea Wang-Gillam, Dung T. Le, Tony Reid, Colin D. Weekes, Zev A. Wainberg, Herbert J. Zeh, Michael A. Morse, Elizabeth M. Jaffee, Amanda Enstrom, Erkut Borazanci, Sandy Ferber, Dirk G. Brockstedt, Hedy L. Kindler, Nitya Nair, Benjamin L. Musher, Aimee Murphy, Paul E. Oberstein, Andrew H. Ko, Daniel A. Laheru, Todd S. Crocenzi, Noelle K. LoConte, Vincent J. Picozzi
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research, vol 25, iss 18
Purpose: Limited options exist for patients with advanced pancreatic cancer progressing after 1 or more lines of therapy. A phase II study in patients with previously treated metastatic pancreatic cancer showed that combining GVAX pancreas (granulocy
Autor:
Robert C.G. Martin, Charles R. Scoggins, William S. Rilling, Clifton M. Tatum, Vivek R. Sharma, Christopher J. Laing, Marshall T. Schreeder, Steven M. Strasberg, Todd S. Crocenzi, Ricardo Garcia-Monaco, Lawrence R. Kelly
Publikováno v:
Cancer. 121:3649-3658
BACKGROUND Reports have demonstrated the superior activity of combining both irinotecan and oxaliplatin (FOLFOXIRI) therapy. An option for gaining similar benefits with less toxicity would be the administration of irinotecan through a hepatic artery
Autor:
Jennifer N. Uram, Andrea Wang-Gillam, Ed Lemmens, Dung T. Le, Justin Skoble, Deirdre Jill Cohen, Daniel A. Laheru, Beth Onners, Robert L. Fine, Todd S. Crocenzi, Michael A. Morse, John Grous, Tim F. Greten, Herbert J. Zeh, Thomas W. Dubensky, Dirk G. Brockstedt, Vincent J. Picozzi, Sara Solt, Gregory M. Springett, Aimee Murphy, Elizabeth M. Jaffee, Eric R. Lutz
Publikováno v:
Journal of Clinical Oncology. 33:1325-1333
Purpose GVAX pancreas, granulocyte-macrophage colony-stimulating factor–secreting allogeneic pancreatic tumor cells, induces T-cell immunity to cancer antigens, including mesothelin. GVAX is administered with low-dose cyclophosphamide (Cy) to inhib
Autor:
C.-H. Hsu, Lixin Lang, Winnie Yeo, Tae Yong Kim, Thomas Yau, Jaclyn Neely, Ignacio Melero, Todd S. Crocenzi, Masatoshi Kudo, Bruno Sangro, Y-K Kang, S.P. Choo, Anthony B. El-Khoueiry, Adyb Baakili, Akhil Chopra, Joerg Trojan, C dela Cruz, Tim Meyer, Theodore H. Welling
Publikováno v:
72. Jahrestagung der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten mit Sektion Endoskopie – 11. Herbsttagung der Deutschen Gesellschaft für Allgemein- und Viszeralchirurgie gemeinsam mit den Arbeitsgemeinschaften der DGAV.